Non-alcoholic fatty liver disease: new additional non-invasive diagnostic markers and risks of comorbid diseases (original) (raw)

Diagnosis and Characterization of Non-Alcoholic Fatty Liver Disease

Javier Crespo

Liver Research and Clinical Management, 2018

View PDFchevron_right

Nonalcoholic Fatty Liver Disease: Epidemiology, Natural History, and Diagnostic Challenges

Edward Pham

Hepatology, 2016

View PDFchevron_right

Non-alcoholic fatty liver disease - the heart of the matter

Stephen Malnick

World Journal of Hepatology, 2015

View PDFchevron_right

Epidemiology of Non-Alcoholic Fatty Liver Disease

Goh Chung

Digestive Diseases, 2010

View PDFchevron_right

A Study of Non Alcoholic Fatty Liver Disease in Metabolic Syndrome Patients

Pinky Karam

SSRN Electronic Journal, 2021

View PDFchevron_right

Non-alcoholic fatty liver: a common manifestation of a metabolic disorder

Stephen Malnick

QJM, 2003

View PDFchevron_right

Silent non-alcoholic fatty liver disease—a clinical–histological study

Paolo Sorrentino

Journal of Hepatology, 2004

View PDFchevron_right

Non alcoholic fatty liver disease. The new millennium pandemia

Adriana Puerta

Revista …, 2010

View PDFchevron_right

Fatty liver, cardiometabolic disease and mortality

Giorgio Bedogni

Current Opinion in Lipidology, 2019

View PDFchevron_right

Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort

Eric Lawitz

World Journal of Hepatology, 2019

View PDFchevron_right

Risk of Ischemic Heart Disease in Patients with Non-alcoholic Fatty Liver Disease

Mostafa Elkady

Afro-Egyptian Journal of Infectious and Endemic Diseases, 2018

View PDFchevron_right

Risk factors associated with non-alcoholic fatty liver disease in subjects from primary care units. A case-control study

Shivaram Singh

BMC Gastroenterology, 2008

View PDFchevron_right

Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures

Dorit Nitzan (Kaluski)

Liver International, 2006

View PDFchevron_right

Obesity and liver disease

Ayman Koteish

Best Practice & Research Clinical Endocrinology & Metabolism, 2002

View PDFchevron_right

External validation of biomarkers of fatty liver in the general population: the Bagnacavallo study

Giorgio Bedogni

Qeios, 2020

View PDFchevron_right

The Risk Factors Of Non-Alcoholic Fatty Liver Disease Prevalence In Obesity With Or Without Diabetes Mellitus

S.M. SUMON

The Internet Journal of Gastroenterology, 2010

View PDFchevron_right

Obesity, Non Alcoholic Fatty Liver Disease (NAFLD) and Coronary Artery Disease (CAD)

Dhastagir Sheriff

Endocrinology & Metabolic Syndrome, 2011

View PDFchevron_right

Nonalcoholic Fatty Liver Disease in Children

Diana Mager

Clinics in Liver Disease, 2006

View PDFchevron_right

Association Between Quantity of Liver Fat and Cardiovascular Risk in Patients with Nonalcoholic Fatty Liver Disease Independent of Nonalcoholic Steatohepatitis

Claude B. Sirlin

Clinical Gastroenterology and Hepatology, 2015

View PDFchevron_right

A Bird's Eye View of Non Alcoholic Fatty Liver Disease - an Insulin Resistant State

faraj ali

Acta Medica Saliniana, 2010

View PDFchevron_right

Heritability of Nonalcoholic Fatty Liver Disease

György Baffy

Gastroenterology, 2009

View PDFchevron_right

Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program

David Kaplan

PLOS ONE, 2020

View PDFchevron_right

Non‐alcoholic fatty liver disease (NAFLD)—Treat to target, but the goalposts are in the wrong place

Yaakov Maor

GastroHep, 2019

View PDFchevron_right

Imaging of nonalcoholic fatty liver disease and its clinical utility

Evangelos Chartampilas

Hormones, 2018

View PDFchevron_right

Non-alcoholic fatty liver disease and diabetes: From physiopathological interplay to diagnosis and treatment

Cristiane Villela-nogueira

World Journal of Gastroenterology, 2014

View PDFchevron_right

Obesity and Metabolic Dysfunction-associated Fatty Liver Disease: Understanding the Intricate Link

Sandhiya Selvarajan

Journal of Translational Gastroenterology, 2023

View PDFchevron_right

Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?

Sagar Rajak

Journal of hepatology, 2017

View PDFchevron_right

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease

richard torstenson

2020

View PDFchevron_right

Nonalcoholic fatty liver disease burden – Switzerland 2018–2030

Beat Müllhaupt

Swiss Medical Weekly, 2019

View PDFchevron_right

Incidence and natural course of fatty liver in the general population: The Dionysos study

Giorgio Bedogni

Hepatology, 2007

View PDFchevron_right

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

George Lau

Journal of Hepatology, 2020

View PDFchevron_right

Steatosis, Steatohepatitis, Nonalcoholic Fatty Liver Disease, and Nonalcoholic Steatohepatitis

Claude B. Sirlin

Gastrointestinal Imaging, 2015

View PDFchevron_right

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD)

Bunchai Chongmelaxme

Medicine, 2016

View PDFchevron_right

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease

nathalie leite

The Lancet Gastroenterology & Hepatology, 2020

View PDFchevron_right

Association of nonalcoholic fatty liver disease with insulin resistance

Priscila Sanches, Lila Oyama

The American Journal of Medicine, 1999

View PDFchevron_right